E-LIB Suche - Ergebnisse für: Polhamus, Daniel

1

Population Pharmacokinetic/Pharmacodynamic Analysis Of Gara..:

Glassman, Fiona ; Sharma, Ankur ; Cheng, Shen...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB4 , 2024

Link: https://doi.org/10.1016/..

2

Exposure–efficacy relationship of vedolizumab subcutaneous ..:

D'Haens, Geert ; Rosario, Maria ; Polhamus, Daniel...
Expert Review of Clinical Pharmacology. 17 (2024) 4 - p. 403-412 , 2024

Link: https://doi.org/10.1080/..

3

Exposure–response analysis of efficacy and safety for pexid..:

Yin, Ophelia ; Zahir, Hamim ; French, Jonathan...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 11 - p. 1422-1432 , 2021

Link: https://doi.org/10.1002/..

4

Sa1868 AN EVALUATION OF THE EXPOSURE-EFFICACY RELATIONSHIP ..:

Chen, Chunlin ; Rosario, Maria ; Polhamus, Daniel...
Gastroenterology. 158 (2020) 6 - p. S-458 , 2020

Link: https://doi.org/10.1016/..

5

Pharmacokinetics of trastuzumab emtansine (T-DM1) as a sing..:

Lu, Dan ; Li, Chunze ; Riggs, Matthew...
Cancer Chemotherapy and Pharmacology. 84 (2019) 1 - p. 175-185 , 2019

Link: https://doi.org/10.1007/..

6

Exposure–response analyses of trastuzumab emtansine in pati..:

Li, Chunze ; Wang, Bei ; Chen, Shang-Chiung...
Cancer Chemotherapy and Pharmacology. 80 (2017) 6 - p. 1079-1090 , 2017

Link: https://doi.org/10.1007/..

7

Population pharmacokinetics and exposure–response of trastu..:

Chen, Shang‐Chiung ; Quartino, Angelica ; Polhamus, Daniel...
British Journal of Clinical Pharmacology. 83 (2017) 12 - p. 2767-2777 , 2017

Link: https://doi.org/10.1111/..

8

P3–301: Clinical dementia rating modeling and simulation: M..:

Polhamus, Daniel ; Rogers, James ; French, Jonathan.
Alzheimer's & Dementia. 9 (2013) 4S_Part_17 - p. , 2013

Link: https://doi.org/10.1016/..

9

A novel model-based meta-analysis to indirectly estimate th..:

Gross, Jorge Luiz ; Rogers, James ; Polhamus, Daniel...
BMJ Open. 3 (2013) 3 - p. e001844 , 2013

Link: https://doi.org/10.1136/..

10

Combining patient-level and summary-level data for Alzheime..:

Rogers, James A. ; Polhamus, Daniel ; Gillespie, William R....
Journal of Pharmacokinetics and Pharmacodynamics. 39 (2012) 5 - p. 479-498 , 2012

Link: https://doi.org/10.1007/..

11

A Phase I, Open-Label, Fixed Sequence Study to Investigate ..:

Tsukada, Hironobu ; Chen, Yu-Luan ; Xiao, Guangqing...
Clinical Pharmacokinetics. 62 (2023) 12 - p. 1755-1763 , 2023

Link: https://doi.org/10.1007/..

12

Population pharmacokinetic analysis of ulotaront in subject..:

Galluppi, Gerald R. ; Polhamus, Daniel G. ; Fisher, Jeannine M...
CPT: Pharmacometrics & Systems Pharmacology. 10 (2021) 10 - p. 1245-1254 , 2021

Link: https://doi.org/10.1002/..

13

Exposure–response analysis of efficacy and safety for pexid..:

Yin, Ophelia ; Zahir, Hamim ; French, Jonathan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592513/. , 2021

Link: http://www.ncbi.nlm.nih...

14

A novel model-based meta-analysis to indirectly estimate th..:

Gross, Jorge Luiz ; Rogers, James ; Polhamus, Daniel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612798. , 2013

Link: http://www.ncbi.nlm.nih...

15

A Phase I, Open-Label, Fixed Sequence Study to Investigate ..:

Tsukada, Hironobu ; Chen, Yu-Luan ; Xiao, Guangqing...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684410/. , 2023

Link: http://www.ncbi.nlm.nih...